Lantern Pharma (LTRN) Tops Q2 EPS by 13c
Lantern Pharma (NASDAQ: LTRN) reported Q2 EPS of ($0.40), $0.13 better than the analyst estimate of ($0.53).
For earnings history and earnings-related data on Lantern Pharma (LTRN) click here.
Lantern Pharma (NASDAQ: LTRN) reported Q2 EPS of ($0.40), $0.13 better than the analyst estimate of ($0.53).
For earnings history and earnings-related data on Lantern Pharma (LTRN) click here.